Catalyst

Slingshot members are tracking this event:

Mylan Appoints Anthony Mauro as the new Chief Commercial Officer

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MYL Community voting in process

Additional Information

Additional Relevant Details Mauro has been with Mylan for more than 20 years and has successfully led its largest commercial business – the North American region – for the last four of them. He has served the company in several capacities of increasing responsibility, including president of Mylan Pharmaceuticals Inc., the company's flagship generics division in the U.S.; chief operating officer of Mylan Pharmaceuticals ULC in Canada; vice president of North America Strategic Development; and vice president of North America Sales. Mauro also served as chairman of the board of directors for the U.S. Generic Pharmaceutical Association (GPhA) for two consecutive terms in 2012 and 2013, and prior to that served two consecutive terms as vice chairman of the board for GPhA.

Mauro said: "I have had the privilege of being part of Mylan for more than 20 years and contributing to the company's evolution from a leading generics pharmaceutical company in the U.S. to a leading global pharmaceutical company. Mylan's future has never been brighter, and I am proud to have been recognized and ready to step up to be a part of Mylan's senior organizational leadership team as we continue our exciting growth trajectory, while delivering on our mission to set new standards in healthcare."
http://newsroom.myla...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 22, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Cfo